← All stocks

REGENXBIO Inc.

RGNX Net buying
CIK 0001590877 #2797 in the set updated 17 Sep 2026
Bought (1 mo)
$949.38K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$949.38K
+$949.38K against sales at will

By person

16 insiders · 2 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ciongoli Gregory Austin
Director
$949.38K (2)
+$949.38K
118,035
0.1788%
$1.10M
Mills Kenneth T.
Director
495,925
0.7513%
$4.64M
+11.6%
Simpson Curran
Chief Executive Officer
338,053
0.5121%
$3.16M
+98.8%
Danos Olivier
Chief Scientific Officer
226,348
0.3429%
$2.12M
+22.3%
Christmas Patrick J.
Chief Strategy & Legal Officer
205,968
0.3120%
$1.93M
+19.6%
PAKOLA STEVE
Chief Medical Officer
205,541
0.3114%
$1.92M
+24.1%
Chan Mitchell
Chief Financial Officer
122,815
0.1860%
$1.15M
+108.6%
Malzahn Craig
Chief Technology Officer
81,960
0.1242%
$766.82K
+360.0%
Zachary Jennifer
Director
31,871
0.0483%
$298.19K
+122.9%
MIGAUSKY GEORGE V
Director
28,861
0.0437%
$270.02K
+155.7%
Tasse Daniel
Director
28,861
0.0437%
$270.02K
+155.7%
STUMP DAVID C
Director
28,861
0.0437%
$270.02K
+155.7%
KARABELAS ARGERIS N
Director
28,861
0.0437%
$270.02K
+155.7%
Glucksmann Alexandra
Director
28,861
0.0437%
$270.02K
+155.7%
Fox Allan M.
Director
28,861
0.0437%
$270.02K
+155.7%
Bennett Jean
Director
28,861
0.0437%
$270.02K
+155.7%
Insider
Date
Role
Action
Shares
Price
Amount
Ciongoli Gregory Austin
27 Aug 2026
Director
Buy
53,407
$9.36
$499.68K
Ciongoli Gregory Austin
26 Aug 2026
Director
Buy
49,196
$9.14
$449.71K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 20,568
History held since 12 Dec 2016